Benzyltrimethylammonium tetrachloroiodate, 10g

Methanol D4, 99.8 at%D, 10 ml, glass packaging

4-((1-(Tert-butoxycarbonyl)piperidin-4-yl)oxy)benzoic acid, 95+%, 1g

2-Bromo-1-(3,5-di-tert-butyl-4-hydroxyphenyl)ethanone, 97.0%, 25g

(S)-1-(1-Phenylethyl)-1H-pyrrole-2,5-dione, 100mg

3-chloro-5,6,7,8-tetrahydrocinnoline, 95.0%, 10g

Fumaronitrile>98.0%(GC)5g

methyl 2-[1-(bromomethyl)cyclopropyl]acetate, 2949.000, 1g

(R)-N-Boc-3-Morpholinecarbaldehyde, 95.0%, 100mg

(R)-4-(tert-Butyl)-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 1g

Zotarolimus, 98.59%, 1mg

2,3,5,6-Tetrafluoro-4-(trifluoromethyl)phenol, 95.0%, 5g

4-Amino-1-benzylpiperidine-4-carboxamide, 98%, 500mg